COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
Document Type
Letter to the Editor
Publication Date
12-1-2020
Journal
The Lancet Neurology
Volume
19
Issue
12
DOI
10.1016/S1474-4422(20)30413-0
APA Citation
Muppidi, S., Guptill, J., Jacob, S., Li, Y., Farrugia, M., Guidon, A., Tavee, J., Kaminski, H., Howard, J., Cutter, G., Wiendl, H., Maas, M., Illa, I., Mantegazza, R., Murai, H., Utsugisawa, K., Nowak, R., Tyagi, A., Sousa, A., Amato, A., Pinto, A., Roy, B., Carmichael, C., Dodig, D., Burke, G., Cutter, G., Lee, I., Guptill, J., Howard, J., Caress, J., Pritchard, J., & Vissing, J. (2020). COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). The Lancet Neurology, 19 (12). http://dx.doi.org/10.1016/S1474-4422(20)30413-0